Viewing Study NCT03292133


Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2026-03-03 @ 2:35 AM
Study NCT ID: NCT03292133
Status: TERMINATED
Last Update Posted: 2025-06-10
First Post: 2017-09-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
Sponsor: Massachusetts General Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 17-291
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View